Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


GREY:BIOAF - Post by User

Comment by narmacon Jan 16, 2023 3:44pm
107 Views
Post# 35226388

RE:RE:RE:RE:Forcing Bioasis to Answer

RE:RE:RE:RE:Forcing Bioasis to AnswerThere is always a Plan B and a pPan C,,,dont kid yourself,,,,these deal makers know exactly what they want to do if the vote is a favourable "NO". Hahahahahahaaha,,, ,,They will come out guns ablazing to take our IP,,,, but they will be confronted with a shareholder take over. Perhaps we could negotiate Mark Day back in the saddle. Pick our own board. Downsize,, raise the $$ for Linds exit and canvass across Canada and grant $$$ for a home grown trial right here. Yep,,, leave the FDA where it is for now,,Prove our science and if it dont work then BTI can vaporize.

On a side note if the vote goes to the YES side,,then when do these prepaid warrants show up in our massive dilution??,,,,as soon as any value might come into the Biodexa share price??,,,maybe 2024,,,the massive 400+ page document of yada yada yada might point to this question,,,but find it is also a task!!!
<< Previous
Bullboard Posts
Next >>